Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America

Research output: Contribution to journalArticle

Abstract

Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of morbidity and mortality in patients with established disease. Secular trends in the prevalence of diabetes mellitus and heart failure forecast a growing burden of disease and underscore the need for effective therapeutic strategies. Recent clinical trials have demonstrated the shared pathophysiology between diabetes mellitus and heart failure, the synergistic effect of managing both conditions, and the potential for diabetes mellitus therapies to modulate the risk of heart failure outcomes. This scientific statement on diabetes mellitus and heart failure summarizes the epidemiology, pathophysiology, and impact of diabetes mellitus and its control on outcomes in heart failure; reviews the approach to pharmacological therapy and lifestyle modification in patients with diabetes mellitus and heart failure; highlights the value of multidisciplinary interventions to improve clinical outcomes in this population; and outlines priorities for future research.

Original languageEnglish (US)
Pages (from-to)e294-e324
JournalCirculation
Volume140
Issue number7
DOIs
StatePublished - Aug 13 2019

Fingerprint

Type 2 Diabetes Mellitus
Heart Failure
Diabetes Mellitus
Guidelines
Life Style
Epidemiology
Therapeutics
Clinical Trials
Pharmacology
Morbidity
Mortality
Population

Keywords

  • AHA Scientific Statement
  • diabetes mellitus, type 2
  • drug therapy
  • heart failure
  • lifestyle
  • risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America (2019). Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation, 140(7), e294-e324. https://doi.org/10.1161/CIR.0000000000000691

Type 2 Diabetes Mellitus and Heart Failure : A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. / American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America.

In: Circulation, Vol. 140, No. 7, 13.08.2019, p. e294-e324.

Research output: Contribution to journalArticle

American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America 2019, 'Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update', Circulation, vol. 140, no. 7, pp. e294-e324. https://doi.org/10.1161/CIR.0000000000000691
American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation. 2019 Aug 13;140(7):e294-e324. https://doi.org/10.1161/CIR.0000000000000691
American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America. / Type 2 Diabetes Mellitus and Heart Failure : A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. In: Circulation. 2019 ; Vol. 140, No. 7. pp. e294-e324.
@article{2a6d3b27927e40659c340325b69beccc,
title = "Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update",
abstract = "Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of morbidity and mortality in patients with established disease. Secular trends in the prevalence of diabetes mellitus and heart failure forecast a growing burden of disease and underscore the need for effective therapeutic strategies. Recent clinical trials have demonstrated the shared pathophysiology between diabetes mellitus and heart failure, the synergistic effect of managing both conditions, and the potential for diabetes mellitus therapies to modulate the risk of heart failure outcomes. This scientific statement on diabetes mellitus and heart failure summarizes the epidemiology, pathophysiology, and impact of diabetes mellitus and its control on outcomes in heart failure; reviews the approach to pharmacological therapy and lifestyle modification in patients with diabetes mellitus and heart failure; highlights the value of multidisciplinary interventions to improve clinical outcomes in this population; and outlines priorities for future research.",
keywords = "AHA Scientific Statement, diabetes mellitus, type 2, drug therapy, heart failure, lifestyle, risk factors",
author = "{American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America} and Dunlay, {Shannon M.} and Givertz, {Michael M.} and David Aguilar and Allen, {Larry A.} and Michael Chan and Desai, {Akshay S.} and Anita Deswal and {Vaughan Dickson}, Victoria and Kosiborod, {Mikhail N.} and Lekavich, {Carolyn L.} and McCoy, {Rozalina G.} and Mentz, {Robert J.} and Pi{\~n}a, {Ileana L.}",
year = "2019",
month = "8",
day = "13",
doi = "10.1161/CIR.0000000000000691",
language = "English (US)",
volume = "140",
pages = "e294--e324",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Type 2 Diabetes Mellitus and Heart Failure

T2 - A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

AU - American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America

AU - Dunlay, Shannon M.

AU - Givertz, Michael M.

AU - Aguilar, David

AU - Allen, Larry A.

AU - Chan, Michael

AU - Desai, Akshay S.

AU - Deswal, Anita

AU - Vaughan Dickson, Victoria

AU - Kosiborod, Mikhail N.

AU - Lekavich, Carolyn L.

AU - McCoy, Rozalina G.

AU - Mentz, Robert J.

AU - Piña, Ileana L.

PY - 2019/8/13

Y1 - 2019/8/13

N2 - Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of morbidity and mortality in patients with established disease. Secular trends in the prevalence of diabetes mellitus and heart failure forecast a growing burden of disease and underscore the need for effective therapeutic strategies. Recent clinical trials have demonstrated the shared pathophysiology between diabetes mellitus and heart failure, the synergistic effect of managing both conditions, and the potential for diabetes mellitus therapies to modulate the risk of heart failure outcomes. This scientific statement on diabetes mellitus and heart failure summarizes the epidemiology, pathophysiology, and impact of diabetes mellitus and its control on outcomes in heart failure; reviews the approach to pharmacological therapy and lifestyle modification in patients with diabetes mellitus and heart failure; highlights the value of multidisciplinary interventions to improve clinical outcomes in this population; and outlines priorities for future research.

AB - Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of morbidity and mortality in patients with established disease. Secular trends in the prevalence of diabetes mellitus and heart failure forecast a growing burden of disease and underscore the need for effective therapeutic strategies. Recent clinical trials have demonstrated the shared pathophysiology between diabetes mellitus and heart failure, the synergistic effect of managing both conditions, and the potential for diabetes mellitus therapies to modulate the risk of heart failure outcomes. This scientific statement on diabetes mellitus and heart failure summarizes the epidemiology, pathophysiology, and impact of diabetes mellitus and its control on outcomes in heart failure; reviews the approach to pharmacological therapy and lifestyle modification in patients with diabetes mellitus and heart failure; highlights the value of multidisciplinary interventions to improve clinical outcomes in this population; and outlines priorities for future research.

KW - AHA Scientific Statement

KW - diabetes mellitus, type 2

KW - drug therapy

KW - heart failure

KW - lifestyle

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=85069624339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069624339&partnerID=8YFLogxK

U2 - 10.1161/CIR.0000000000000691

DO - 10.1161/CIR.0000000000000691

M3 - Article

C2 - 31167558

AN - SCOPUS:85069624339

VL - 140

SP - e294-e324

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 7

ER -